Your browser doesn't support javascript.
loading
Pharmacoepitranscriptomic landscape revealing m6A modification could be a drug-effect biomarker for cancer treatment.
Liu, Ke; Ouyang, Qian-Ying; Zhan, Yan; Yin, Hui; Liu, Bo-Xuan; Tan, Li-Ming; Liu, Rong; Wu, Wei; Yin, Ji-Ye.
Afiliação
  • Liu K; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, P.R. China.
  • Ouyang QY; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan 410078, P.R. China.
  • Zhan Y; Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, Changsha, P.R. China.
  • Yin H; National Clinical Research Center for Geriatric Disorders, Changsha, P.R. China.
  • Liu BX; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, P.R. China.
  • Tan LM; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan 410078, P.R. China.
  • Liu R; Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, Changsha, P.R. China.
  • Wu W; National Clinical Research Center for Geriatric Disorders, Changsha, P.R. China.
  • Yin JY; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, P.R. China.
Mol Ther Nucleic Acids ; 28: 464-476, 2022 Jun 14.
Article em En | MEDLINE | ID: mdl-35505958

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Mol Ther Nucleic Acids Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Mol Ther Nucleic Acids Ano de publicação: 2022 Tipo de documento: Article